Liver function: Research has shown that semaglutide results in improved liver fat and scarring, and MASH (which stands for metabolic dysfunction-associated steatohepatitis) is an FDA-approved indication
reproductive endpoints typically appear in dedicated mechanistic studies or post-marketing investigations rather than primary efficacy trials
Differences across dose subgroups The recommended doses of tirzepatide are 2.5 mg, 5.0 mg, 7.5 mg, 10.0 mg, 12.5 mg, or 15.0 mg administered via subcutaneous injection weekly
If ketoacidosis is suspected, discontinue SYNJARDY or SYNJARDY XR, promptly evaluate, and treat ketoacidosis, if confirmed
Use it before every injection until the calculation becomes second nature
Pereira AR, Moura LH, Pinheiro JR, Pasin VP, Enokihara MM, Porro AM (2016) Vancomycin-associated linear IgA disease mimicking toxic epidermal necrolysis